← Back to Intel
Insider ActivityORMP
Kidron Miriam, Chief Scientific Officer, Director at ORAMED PHARMACEUTICALS INC., traded $1.4M of ORMP
Updated Jun 13, 2026
Kidron Miriam
Chief Scientific Officer, Director
ORAMED PHARMACEUTICALS INC. ·
$ORMP
Transaction Details
| Insider | Kidron Miriam |
|---|---|
| Title | Chief Scientific Officer, Director |
| Company | ORAMED PHARMACEUTICALS INC. |
| Ticker | ORMP |
| Transaction Type | Tax |
| Transaction Date | 2026-03-30 |
| Shares Traded | 435,084 |
| Price Per Share | $3.31 |
| Total Value | $1.4M |
| Filed Date | 2026-03-31 |
| Accession Number | 0001213900-26-037446 |
Ownership Context
| Shares Owned After Transaction | 1,133,138 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001213900-26-037446
Other Insider Trades — ORMP
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| KIDRON NADAV | President and CEO, Director | traded | $148K | 2026-03-30 |
Other Trades by Kidron Miriam
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| LFWD | Lifeward Ltd. | traded | — | 2026-03-25 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ORMP — ORAMED PHARMACEUTICALS INC. →
Track ORMP insider activity in real time on The Wire →
Get alerts when Kidron Miriam files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 13, 2026 at 07:19 UTC